Point-of-care diagnostics is the medical diagnostic testing at the time and place of the patient care. It allows a convenient, speedy, and cost-efficient way to treat diseases at clinics, healthcare centres and hospitals. This testing are simple medical tests that can be performed at the bedside which make the treatment simple and efficient. The innovative technology and advanced point-of-care devices, made an extensive impact on the growth of the Point-of-care diagnostics market.
Asia-Pacific Point-Of-Care Diagnostics Market: Drivers & Restraints Rise in clinics and other healthcare establishments, advances in technology, cost effective and high quality medical solutions, point-of-care diagnostic consumables and medical devices, favourable government reimbursements and high investments of private companies are driving the Asia-Pacific Point-of-care Diagnostics Market. However, reluctance from the industry towards changing the existing norms and stringent regulatory framework are hindering the market growth.
Asia-Pacific Point-Of-Care Diagnostics Market: Segmentation By Product • Infectious Diseases • Cardiac Markers • Oncology Markers • OTC Diagnostic Tests • Drugs of Abuse • Blood Gas Testing • Fertility Testing • Urinalysis • Coagulation • Hematology • Glucose Monitoring • Ambulatory Chemistry • Decentralized Clinical Chemistry • Others By End-Users • Clinics • Hospitals • Home Healthcare • Ambulatory Care Settings • Laboratories • Others By Mode of Delivery • OTC • Prescription By Geography • Asia-Pacific o China o India o Japan o Australia o South Korea
Asia-Pacific Point-Of-Care Diagnostics Market: Overview Based on the products, oncology segment has the largest share in terms of revenue due to the rise in cancer related diseases and growing aged population while infectious diseases are estimated to have the fastest growing rate in the forecast period. In End-Users, clinics is projected to have the highest share in terms of revenue.
In 2017, Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region due to the increasing initiatives by market players, emerging markets such as China and India, rise in the number of partnerships and joint ventures among point-of-care providers and growing patient population base.
Asia-Pacific Point-Of-Care Diagnostics Market: Key Players Some of the key players in this market are Danaher Corporation, Abbott Laboratories, Inc., Roche Diagnostics Limited and Siemens Healthcare. Other companies include Beckman Coulter, Inc., BioMerieux, Johnson & Johnson, Becton, Dickinson and Company, Alere Inc., and PTS Diagnostics.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.